ru uk en

LEGAL ALLIANCE, founded in 1995, is today one of the leading Ukrainian law firms specializing in legal support to pharmaceutical companies doing business in Ukraine and CIS countries.

OUR CLIENTS represent the following industries: pharmaceuticals, medical devices, consumer goods, medicine, cosmetics, para-pharmaceuticals, chemistry, biotechnology, agriculture and food products.

LEADING ASSOCIATIONS — AIPM Ukraine, APRaD as well as the EBA Healthcare Committee have chosen Legal Alliance as their legal advisor.

On November 4th, Legal Alliance Company with the support of the Association of Innovative Drug Manufacturers “APRaD” held the discussion club “Discussion Pharma MeetUP on Intellectual Property: Manufacturers of Innovative Drugs vs Generics Manufacturers on Bills No. 2089 and No. 2259.” Details of the discussion in the article from
Vitalii Savchuk, counsel at Legal Alliance Company, comments to the Interfax-Ukraine agency on the main provisions of the bill on amending certain legislative acts to increase the availability of medicines for the population (No. 2089).
Khrystyna Sushkevych, associate at Legal Alliance Company, told readers of Yuryst&Zakon about unfair competition in the context of goodwill and the importance of complying with the rules of competition by all participants in market relations for efficient business activities.
Lawyer&Law, No17, May 9th, 2019. Protection of intellectual property rights to objects created by artificial intellect
Yuridicheskaya Gazeta, 27.11.2018Natalia Lavrenova, attorney-at-law, associated partner at Legal Alliance Company Nataliia Abramovych, associate at Legal Allia
How much talcum do you need in fact, if in the formula of your patent its mass fraction is equal to 1%? Can you prove it in court?
The law is indifferent to the good intention of patent invalidation, but attentive to the reasons therefor. This means that the court cannot be guided only by ideas of situational public interest - it must apply the norms of the law. The law in its turn (ideally) is designed to take into account the public interest all the time.
The entry into force of amendments to the TRIPS allows the developed states to issue compulsory licenses to generic pharmaceutical companies for the production of medicinal products, allowing them to export the product to developing countries. This mechanism is very interesting for the domestic pharmaceutical industry.
Legal Alliance lawyers speak on the practice of domain disputes solutions in Ukraine and Europe.
Pro Bono services in Ukraine, unlike Western Europe or the United States, can only be described as not very popular and for some Ukrainian law firms it is a completely unknown phenomenon.
If you find out a mistake, please, mark it and select Ctrl+Enter to inform us